Effect of Quercetin-Loaded Mesoporous Silica Nanoparticles on Myocardial Ischemia-Reperfusion Injury in Rats and Its Mechanism

References

• Maddison R, Rawstorn JC, Shariful Islam SM, et al. mHealth interventions for exercise and risk factor modification in cardiovascular disease. Exerc Sport Sci Rev. 2019;47(2):86–90. doi:10.1249/JES.0000000000000185
   PubMedGoogle Scholar
• Salas-Salvado J, Becerra-Tomas N, Garcia-Gavilan JF, Bullo M, Barrubes L. Mediterranean diet and cardiovascular disease prevention: what do we know? Prog Cardiovasc Dis. 2018;61(1):62–67. doi:10.1016/j.pcad.2018.04.006
   PubMed Web of Science ®Google Scholar
• Morris CJ, Purvis TE, Hu K, Scheer FA. Circadian misalignment increases cardiovascular disease risk factors in humans. Proc Natl Acad Sci U S A. 2016;113(10):E1402–1411. doi:10.1073/pnas.1516953113
   PubMed Web of Science ®Google Scholar
• Carter S, Hartman Y, Holder S, Thijssen DH, Hopkins ND. Sedentary behavior and cardiovascular disease risk: mediating mechanisms. Exerc Sport Sci Rev. 2017;45(2):80–86. doi:10.1249/JES.0000000000000106
   PubMed Web of Science ®Google Scholar
• Koliaki C, Liatis S, Kokkinos A. Obesity and cardiovascular disease: revisiting an old relationship. Metabolism. 2019;92:98–107. doi:10.1016/j.metabol.2018.10.011
   PubMed Web of Science ®Google Scholar
• Allgulander C. Anxiety as a risk factor in cardiovascular disease. Curr Opin Psychiatry. 2016;29(1):13–17. doi:10.1097/YCO.0000000000000217
   PubMed Web of Science ®Google Scholar
• Kivimaki M, Steptoe A. Effects of stress on the development and progression of cardiovascular disease. Nat Rev Cardiol. 2018;15(4):215–229. doi:10.1038/nrcardio.2017.189
   PubMed Web of Science ®Google Scholar
• Ibanez B, Heusch G, Ovize M, Van de Werf F. Evolving therapies for myocardial ischemia/reperfusion injury. J Am Coll Cardiol. 2015;65(14):1454–1471. doi:10.1016/j.jacc.2015.02.032
   PubMed Web of Science ®Google Scholar
• Penela P, Inserte J, Ramos P, Rodriguez-Sinovas A, Garcia-Dorado D, Mayor F. Degradation of GRK2 and AKT is an early and detrimental event in myocardial ischemia/reperfusion. EBioMedicine. 2019;48:605–618. doi:10.1016/j.ebiom.2019.09.019
   PubMedGoogle Scholar
• Han Y, Wu N, Xia F, Liu S, Jia D. Long noncoding RNA GAS5 regulates myocardial ischemia-reperfusion injury through the PI3K/AKT apoptosis pathway by sponging miR5325p. Int J Mol Med. 2020;45(3):858–872. doi:10.3892/ijmm.2020.4471
   PubMedGoogle Scholar
• Conklin DJ, Guo Y, Nystoriak MA, et al. TRPA1 channel contributes to myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 2019;316(4):H889–H899. doi:10.1152/ajpheart.00106.2018
   PubMedGoogle Scholar
• Chen X, Wang Y, Xiao ZY, Hou DN, Li DB, Zhang XP. Effect of propofol on myocardial ischemia/reperfusion injury in rats through JAK/STAT signaling pathway. Eur Rev Med Pharmacol Sci. 2019;23(14):6330–6338. doi:10.26355/eurrev_201907_18456
   PubMed Web of Science ®Google Scholar
• Xu Z, Steffen LM, Selvin E, Rebholz CM. Diet quality, change in diet quality and risk of incident CVD and diabetes. Public Health Nutr. 2020;23(2):329–338. doi:10.1017/S136898001900212X
   PubMed Web of Science ®Google Scholar
• Alissa EM, Ferns GA. Dietary fruits and vegetables and cardiovascular diseases risk. Crit Rev Food Sci Nutr. 2017;57(9):1950–1962. doi:10.1080/10408398.2015.1040487
   PubMed Web of Science ®Google Scholar
• Rees A, Dodd GF, Spencer JPE. The effects of flavonoids on cardiovascular health: a review of human intervention trials and implications for cerebrovascular function. Nutrients. 2018;10(12):1852. doi:10.3390/nu10121852
   PubMed Web of Science ®Google Scholar
• Liskova A, Koklesova L, Samec M, et al. Flavonoids in cancer metastasis. Cancers(Basel). 2020;12(6):1498.
   PubMedGoogle Scholar
• Kim Y, Je Y. Flavonoid intake and mortality from cardiovascular disease and all causes: a meta-analysis of prospective cohort studies. Clin Nutr ESPEN. 2017;20:68–77. doi:10.1016/j.clnesp.2017.03.004
   PubMed Web of Science ®Google Scholar
• Patel RV, Mistry BM, Shinde SK, Syed R, Singh V, Shin HS. Therapeutic potential of quercetin as a cardiovascular agent. Eur J Med Chem. 2018;155:889–904. doi:10.1016/j.ejmech.2018.06.053
   PubMed Web of Science ®Google Scholar
• Ashrafizadeh M, Ahmadi Z, Farkhondeh T, Samarghandian S. Autophagy as a molecular target of quercetin underlying its protective effects in human diseases. Arch Physiol Biochem. 2019;1–9. doi:10.1080/13813455.2019.1671458
   PubMed Web of Science ®Google Scholar
• Najafi M, Tavakol S, Zarrabi A, Ashrafizadeh M. Dual role of quercetin in enhancing the efficacy of cisplatin in chemotherapy and protection against its side effects: a review. Arch Physiol Biochem. 2020;1–15. doi:10.1080/13813455.2020.1773864
   Google Scholar
• Bartekova M, Radosinska J, Pancza D, Barancik M, Ravingerova T. Cardioprotective effects of quercetin against ischemia-reperfusion injury are age-dependent. Physiol Res. 2016;65(Suppl 1):S101–107. doi:10.33549/physiolres.933390
   PubMedGoogle Scholar
• Dong LY, Chen F, Xu M, Yao LP, Zhang YJ, Zhuang Y. Quercetin attenuates myocardial ischemia-reperfusion injury via downregulation of the HMGB1-TLR4-NF-kappaB signaling pathway. Am J Transl Res. 2018;10(5):1273–1283.
   PubMedGoogle Scholar
• Tang J, Lu L, Liu Y, et al. Quercetin improve ischemia/reperfusion-induced cardiomyocyte apoptosis in vitro and in vivo study via SIRT1/PGC-1α signaling. J Cell Biochem. 2019;120(6):9747–9757. doi:10.1002/jcb.28255
   PubMedGoogle Scholar
• Wan L, Xia J, Ye D, Liu J, Chen J, Wang G. Effects of quercetin on gene and protein expression of NOX and NOS after myocardial ischemia and reperfusion in rabbit. Cardiovasc Ther. 2009;27(1):28–33. doi:10.1111/j.1755-5922.2009.00071.x
   PubMedGoogle Scholar
• Vinayak M, Maurya AK. Quercetin loaded nanoparticles in targeting cancer: recent development. Anticancer Agents Med Chem. 2019;19(13):1560–1576.
   PubMed Web of Science ®Google Scholar
• Ahmad N, Ahmad R, Alam MA, Samim M, Iqbal Z, Ahmad FJ. Quantification and evaluation of thymoquinone loaded mucoadhesive nanoemulsion for treatment of cerebral ischemia. Int J Biol Macromol. 2016;88:320–332. doi:10.1016/j.ijbiomac.2016.03.019
   PubMed Web of Science ®Google Scholar
• Ahmad N, Alam MA, Ahmad R, Umar S, Ahmad FJ. Improvement of oral efficacy of irinotecan through biodegradable polymeric nanoparticles through invitro and invivo investigations. J Microencapsul. 2018;35(4):327–343. doi:10.1080/02652048.2018.1485755
   PubMed Web of Science ®Google Scholar
• Ahmad N, Ahmad R, Ahmad FJ, et al. Poloxamer-Chitosan-based Naringenin nanoformulation used in brain targeting for the treatment of Cerebral Ischemia. Saudi J Biol Sci. 2020;27(1):500–517. doi:10.1016/j.sjbs.2019.11.008
   PubMed Web of Science ®Google Scholar
• Ugazio E, Gastaldi L, Brunella V, et al. Thermoresponsive mesoporous silica nanoparticles as a carrier for skin delivery of quercetin. Int J Pharm. 2016;511(1):446–454. doi:10.1016/j.ijpharm.2016.07.024
   PubMedGoogle Scholar
• Sapino S, Ugazio E, Gastaldi L, et al. Mesoporous silica as topical nanocarriers for quercetin: characterization and in vitro studies. Eur J Pharm Biopharm. 2015;89:116–125. doi:10.1016/j.ejpb.2014.11.022
   PubMed Web of Science ®Google Scholar
• Wang G, Wang JJ, Chen XL, et al. The JAK2/STAT3 and mitochondrial pathways are essential for quercetin nanoliposome-induced C6 glioma cell death. Cell Death Dis. 2013;4:e746. doi:10.1038/cddis.2013.242
   PubMed Web of Science ®Google Scholar
• Cao HH, Tse AK, Kwan HY, et al. Quercetin exerts anti-melanoma activities and inhibits STAT3 signaling. Biochem Pharmacol. 2014;87(3):424–434. doi:10.1016/j.bcp.2013.11.008
   PubMed Web of Science ®Google Scholar
• Sarkar A, Ghosh S, Chowdhury S, Pandey B, Sil PC. Targeted delivery of quercetin loaded mesoporous silica nanoparticles to the breast cancer cells. Biochim Biophys Acta. 2016;1860(10):2065–2075. doi:10.1016/j.bbagen.2016.07.001
   PubMed Web of Science ®Google Scholar
• Zhao J, Liu J, Wei T, et al. Quercetin-loaded nanomicelles to circumvent human castration-resistant prostate cancer in vitro and in vivo. Nanoscale. 2016;8(9):5126–5138. doi:10.1039/C5NR08966B
   PubMedGoogle Scholar
• Manzano García M, Vallet Regí M. Progress report on mesoporous silica nanoparticles for drug delivery. Adv Funct Mater. 2019;1902634.
   Google Scholar
• Ahmad N, Ahmad R, Alrasheed RA, et al. Quantification and evaluations of catechin hydrate polymeric nanoparticles used in brain targeting for the treatment of epilepsy. Pharmaceutics. 2020;12(3):203. doi:10.3390/pharmaceutics12030203
   PubMed Web of Science ®Google Scholar
• Chen F, Zhao ER, Hableel G, et al. Increasing the efficacy of stem cell therapy via triple-function inorganic nanoparticles. ACS Nano. 2019;13(6):6605–6617. doi:10.1021/acsnano.9b00653
   PubMedGoogle Scholar
• Lemaster JE, Chen F, Kim T, Hariri A, Jokerst JV. The development of a trimodal contrast agent for acoustic and magnetic particle imaging of stem cells. ACS Appl Nano Mater. 2018;1(3):1321–1331. doi:10.1021/acsanm.8b00063
   PubMedGoogle Scholar
• Sulaiman D, Li J, Devarajan A, et al. Paraoxonase 2 protects against acute myocardial ischemia-reperfusion injury by modulating mitochondrial function and oxidative stress via the PI3K/Akt/GSK-3beta RISK pathway. J Mol Cell Cardiol. 2019;129:154–164. doi:10.1016/j.yjmcc.2019.02.008
   PubMed Web of Science ®Google Scholar
• Li P, Lin N, Guo M, Huang H, Yu T, Zhang L. REDD1 knockdown protects H9c2 cells against myocardial ischemia/reperfusion injury through Akt/mTORC1/Nrf2 pathway-ameliorated oxidative stress: an in vitro study. Biochem Biophys Res Commun. 2019;519(1):179–185. doi:10.1016/j.bbrc.2019.08.095
   PubMed Web of Science ®Google Scholar
• Ding S, Liu D, Wang L, Wang G, Zhu Y. Inhibiting microRNA-29a protects myocardial ischemia-reperfusion injury by targeting SIRT1 and suppressing oxidative stress and NLRP3-mediated pyroptosis pathway. J Pharmacol Exp Ther. 2020;372(1):128–135. doi:10.1124/jpet.119.256982
   PubMed Web of Science ®Google Scholar
• Liu Y, Che G, Di Z, Sun W, Tian J, Ren M. Calycosin-7-O-beta-D-glucoside attenuates myocardial ischemia-reperfusion injury by activating JAK2/STAT3 signaling pathway via the regulation of IL-10 secretion in mice. Mol Cell Biochem. 2020;463(1–2):175–187. doi:10.1007/s11010-019-03639-z
   PubMedGoogle Scholar
• Chen B, Yang L, Chen J, et al. Inhibition of Connexin43 hemichannels with Gap19 protects cerebral ischemia/reperfusion injury via the JAK2/STAT3 pathway in mice. Brain Res Bull. 2019;146:124–135. doi:10.1016/j.brainresbull.2018.12.009
   PubMed Web of Science ®Google Scholar
• Das A, Salloum FN, Durrant D, Ockaili R, Kukreja RC. Rapamycin protects against myocardial ischemia-reperfusion injury through JAK2-STAT3 signaling pathway. J Mol Cell Cardiol. 2012;53(6):858–869. doi:10.1016/j.yjmcc.2012.09.007
   PubMedGoogle Scholar
• Yang Y, Duan W, Jin Z, et al. JAK2/STAT3 activation by melatonin attenuates the mitochondrial oxidative damage induced by myocardial ischemia/reperfusion injury. J Pineal Res. 2013;55(3):275–286. doi:10.1111/jpi.12070
   PubMed Web of Science ®Google Scholar
• Huang C, Chen T, Zhu D, Huang Q. Enhanced tumor targeting and radiotherapy by quercetin loaded biomimetic nanoparticles. Front Chem. 2020;8:225. doi:10.3389/fchem.2020.00225
   PubMed Web of Science ®Google Scholar
• Ashrafizadeh M, Rafiei H, Mohammadinejad R, Afshar EG, Farkhondeh T, Samarghandian S. Potential therapeutic effects of curcumin mediated by JAK/STAT signaling pathway: a review. Phytother Res. 2020;34(8):1745–1760. doi:10.1002/ptr.6642
   PubMedGoogle Scholar
• Ashrafizadeh M, Zarrabi A, Orouei S, et al. STAT3 pathway in gastric cancer: signaling, therapeutic targeting and future prospects. Biology (Basel). 2020;9(6):126. doi:10.3390/biology9060126
   PubMed Web of Science ®Google Scholar